However, FGF-23 can significantly suppress the synthesis of activated vitamin D, 1α,25-dihydroxyvitamin D. As the CKD progresses, further decreases in activated vitamin D and increases in the serum phosphorus levels can cause hypocalcemia. The gene discussed is FGF23; the disease is chronic kidney disease.